Paper73011
Antibiotic-induced colitis implication of a toxin neutralised by Clostridium sordellii antitoxin.
Rifkin GD and 2 others. Lancet, 1977. Cited by 243 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Antibiotic-induced colitis implication of a toxin neutralised by Clostridium sordellii antitoxin. Papers, record 73011. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/73011
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Antibiotic-induced colitis implication of a toxin neutralised by Clostridium sordellii antitoxin.
- PubMed
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antitoxins | Major topic |
| Bacterial Toxins | Major topic |
| Clostridium | Major topic |
| Enterocolitis, Pseudomembranous | Major topic |
| Adolescent | |
| Animals | |
| Anti-Bacterial Agents | |
| Cricetinae | |
| Culture Techniques | |
| Female | |
| Humans | |
| Infant | |
| Male | |
| Rabbits | |
| Surgical Wound Infection | |
| Urinary Tract Infections |
Source PubMed
Cited by70
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 243 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 38,421,181 | Clostridioides difficile infection: history, epidemiology, risk factors, prevention, clinical manifestations, treatment, and future options. | Clin Microbiol Rev | 2024 | https://conductscience.org/library/papers/38421181 | PubMed |
| 31,941,691 | Prospective Evaluation of the mariPOC Test for Detection of Clostridioides difficile Glutamate Dehydrogenase and Toxins A/B. | J Clin Microbiol | 2020 | https://conductscience.org/library/papers/31941691 | PubMed |
| 27,619,640 | Therapeutic manipulation of the microbiota: past, present, and considerations for the future. | Clin Microbiol Infect | 2016 | https://conductscience.org/library/papers/27619640 | PubMed |
| 26,404,991 | Dentists, antibiotics and Clostridium difficile-associated disease. | Br Dent J | 2015 | https://conductscience.org/library/papers/26404991 | PubMed |
| 24,410,618 | Clostridium difficile infection: molecular pathogenesis and novel therapeutics. | Expert Rev Anti Infect Ther | 2014 | https://conductscience.org/library/papers/24410618 | PubMed |
| 24,187,445 | Clostridium difficile infection in the community: are proton pump inhibitors to blame? | World J Gastroenterol | 2013 | https://conductscience.org/library/papers/24187445 | PubMed |
| 24,064,435 | Epidemiology of Clostridium difficile infection. | J Pharm Pract | 2013 | https://conductscience.org/library/papers/24064435 | PubMed |
| 23,727,391 | A clinical and epidemiological review of non-toxigenic Clostridium difficile. | Anaerobe | 2013 | https://conductscience.org/library/papers/23727391 | PubMed |
| 22,700,832 | Diarrhea etiology in a pediatric emergency department: a case control study. | Clin Infect Dis | 2012 | https://conductscience.org/library/papers/22700832 | PubMed |
| 22,346,513 | Drug risk factors associated with a sustained outbreak of Clostridium difficile diarrhea in a teaching hospital. | Can J Infect Dis | 1994 | https://conductscience.org/library/papers/22346513 | PubMed |
| 18,650,353 | Metronidazole resistance in Clostridium difficile is heterogeneous. | J Clin Microbiol | 2008 | https://conductscience.org/library/papers/18650353 | PubMed |
| 18,473,400 | Recent developments on the role of Clostridium difficile in inflammatory bowel disease. | World J Gastroenterol | 2008 | https://conductscience.org/library/papers/18473400 | PubMed |
| 17,987,387 | Ileal smooth muscle motility depression on rabbit induced by toxin A from Clostridium difficile. | Dig Dis Sci | 2008 | https://conductscience.org/library/papers/17987387 | PubMed |
| 16,424,922 | Colitis due to Clostridium difficile toxins: underdiagnosed, highly virulent, and nosocomial. | Proc (Bayl Univ Med Cent) | 2006 | https://conductscience.org/library/papers/16424922 | PubMed |
| 15,728,918 | In vitro activity of ramoplanin against Clostridium difficile, including strains with reduced susceptibility to vancomycin or with resistance to metronidazole. | Antimicrob Agents Chemother | 2005 | https://conductscience.org/library/papers/15728918 | PubMed |
| 14,992,445 | Clostridium difficile colitis in children with cystic fibrosis. | Dig Dis Sci | 2004 | https://conductscience.org/library/papers/14992445 | PubMed |
| 12,574,264 | Six rapid tests for direct detection of Clostridium difficile and its toxins in fecal samples compared with the fibroblast cytotoxicity assay. | J Clin Microbiol | 2003 | https://conductscience.org/library/papers/12574264 | PubMed |
| 12,019,070 | Reassessment of Clostridium difficile susceptibility to metronidazole and vancomycin. | Antimicrob Agents Chemother | 2002 | https://conductscience.org/library/papers/12019070 | PubMed |
| 11,959,617 | In vitro activity of linezolid against Clostridium difficile. | Antimicrob Agents Chemother | 2002 | https://conductscience.org/library/papers/11959617 | PubMed |
| 10,678,912 | New method to generate enzymatically deficient Clostridium difficile toxin B as an antigen for immunization. | Infect Immun | 2000 | https://conductscience.org/library/papers/10678912 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/73011
GET https://conductscience.org/api/papers/v1/73011/cited_by?page=2